Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

PCOS showdown: which drug tames hormones better?

NCT ID NCT07459595

First seen Mar 18, 2026 · Last updated Jun 19, 2026 · Updated 11 times

Summary

This study compares two drugs—metformin and myo-inositol—for managing polycystic ovary syndrome (PCOS) in 60 women. Over 3 months, researchers will check if either drug helps restore regular menstrual cycles and improve hormone balance. The goal is to see which option works better for common PCOS symptoms like irregular periods and excess hair growth.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for POLYCYSTIC OVARIAN SYNDROME (PCOS) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • CMH Gujranwala

    Guiranwala, Punjab Province, 52230, Pakistan

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Metformin and myo-inositol

What this could lead to

If one works better, it could offer a simpler, more effective option for managing PCOS symptoms like irregular periods and hormone levels.

What could go wrong

This is a very early, small phase 1 trial with only 60 participants, so results may not apply broadly. Both drugs have known side effects like stomach upset.

Conditions

The condition(s) this trial relates to.

polycystic ovary syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.